biotechnology - Patent Detectives

CureVac Sues Moderna Over mRNA Vaccine Patents, Adding to COVID-19 IP Litigation Wave

German biotech company CureVac SE, now a subsidiary of BioNTech, filed a patent infringement lawsuit against Moderna in ...

2026.04.29

パテント探偵社編集部

IP News

Federal Circuit Reinstates $177 Million Verdict in Teva v. Lilly CGRP Antibody Patent Case

The U.S. Court of Appeals for the Federal Circuit reinstated a $177 million jury verdict in Teva Pharmaceuticals Interna...

2026.04.28

パテント探偵社編集部

IP News

Supreme Court to Hear Hikma v. Amarin on April 29, Weighing Skinny Label and Induced Infringement

The U.S. Supreme Court will hear oral argument on April 29, 2026, in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, In...

2026.04.27

パテント探偵社編集部

IP News

U.S. Supreme Court to Hear Oral Arguments April 29 in Hikma v. Amarin — Skinny Label and Induced Infringement Standard at Stake

The U.S. Supreme Court is scheduled to hear oral arguments on April 29, 2026, in Hikma Pharmaceuticals USA Inc. v. Amari...

2026.04.24

パテント探偵社編集部

IP News

Japan IP High Court Revives Broad Institute’s CRISPR Patent, Overturning JPO Priority Rights Ruling

Japan's Intellectual Property High Court (IP High Court) has overturned a Japan Patent Office (JPO) decision invalidatin...

2026.04.24

パテント探偵社編集部

IP News

Federal Circuit Revives $177 Million Jury Verdict in Teva v. Eli Lilly CGRP Patent Dispute, Distinguishing Amgen

The U.S. Court of Appeals for the Federal Circuit on April 16, 2026 reversed a district court's grant of judgment as a m...

2026.04.22

パテント探偵社編集部

IP News

Federal Circuit Reverses Teva Headache Patent Invalidity, Distinguishing Amgen on §112 Written Description and Enablement

The U.S. Court of Appeals for the Federal Circuit issued a precedential opinion on April 16, 2026, reversing a judgment ...

2026.04.19

パテント探偵社編集部

IP News

EPO 2026 Revised Examination Guidelines Take Effect: Antibody Patentability Standard Overhauled, PACE Search Abolished

The European Patent Office (EPO) brought its 2026 consolidated Guidelines for Examination into force on April 1, 2026, s...

2026.04.15

パテント探偵社編集部

IP News

CRISPR Patent War: UC Berkeley vs. Broad Institute and the Battle Over Gene Editing’s Crown

The decade-long CRISPR-Cas9 patent war between UC Berkeley's Jennifer Doudna and Broad Institute's Feng Zhang reshaped biotech IP forever. A deep investigation into the interference proceedings, Nobel Prize, and what it means for medicine.

2026.03.30

パテント探偵社編集部

IP News